Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.95B | 4.05B | 5.87B | 5.19B | 3.10B |
Gross Profit | 1.16B | 1.06B | 2.12B | 2.34B | 1.13B |
EBITDA | 693.50M | 597.02M | 1.51B | 1.72B | 743.82M |
Net Income | 482.28M | 400.67M | 1.16B | 1.29B | 502.63M |
Balance Sheet | |||||
Total Assets | 7.20B | 7.03B | 7.08B | 7.62B | 6.78B |
Cash, Cash Equivalents and Short-Term Investments | 290.66M | 263.67M | 421.70M | 324.88M | 422.68M |
Total Debt | 653.06M | 678.91M | 746.46M | 1.04B | 1.54B |
Total Liabilities | 1.26B | 1.23B | 1.44B | 2.04B | 2.34B |
Stockholders Equity | 5.94B | 5.80B | 5.63B | 5.57B | 4.44B |
Cash Flow | |||||
Free Cash Flow | 282.02M | 142.21M | 955.86M | 762.12M | 348.55M |
Operating Cash Flow | 1.06B | 756.45M | 1.57B | 1.43B | 827.06M |
Investing Cash Flow | -826.47M | -613.69M | -610.62M | -676.51M | -476.20M |
Financing Cash Flow | -265.43M | -298.37M | -840.28M | -870.29M | -195.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$4.00B | 7.03 | 9.36% | 6.05% | -2.46% | 20.39% | |
68 Neutral | HK$18.94B | 22.73 | 6.03% | 0.87% | -4.04% | 44.12% | |
58 Neutral | HK$16.63B | 4.29 | -4.93% | 4.55% | -5.74% | -81.55% | |
58 Neutral | HK$2.23B | 3.74 | 11.49% | ― | 47.32% | 492.76% | |
57 Neutral | HK$900.37M | 9.82 | 4.75% | 2.41% | -13.75% | -56.14% | |
54 Neutral | HK$1.17B | 16.02 | 2.75% | 3.76% | -11.89% | -69.45% | |
54 Neutral | HK$10.65B | 478.00 | 0.15% | 0.93% | 1.42% | -97.94% |
Lee & Man Chemical Company Limited reported a significant 36% increase in profit to HK$327 million for the first half of 2025, driven by reduced energy costs and lower raw material prices. The company’s gross profit margin improved by 7.4 percentage points to 36.3%, and it proposed an interim dividend of HK19.5 cents per share, up from HK14 cents in the previous year, indicating strong financial performance and positive implications for stakeholders.
Lee & Man Chemical Co. Ltd. has announced an interim cash dividend of HKD 0.195 per share for the six months ended 30 June 2025, with the payment date set for 09 September 2025. This announcement reflects the company’s financial performance and commitment to returning value to shareholders, potentially enhancing its market position and stakeholder confidence.
Lee & Man Chemical Co. Ltd. has announced a board meeting scheduled for 7 August 2025 to approve the interim results for the first half of the year and to consider the recommendation for an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
Lee & Man Chemical Co. Ltd. announced the successful passing of all ordinary resolutions during their Annual General Meeting held on May 8, 2025. The resolutions included the adoption of financial statements, declaration of dividends, re-election of directors, and authorization of director remuneration. The meeting saw full participation from shareholders, with no abstentions, and all resolutions were passed with overwhelming support, indicating strong shareholder confidence in the company’s governance and strategic direction.